Bayer AG signs refinancing of EUR3.5bn Revolving Credit Facility

Facility closed significantly oversubscribed

Leverkusen, – Bayer AG announced today that it has signed a EUR3.5bn Revolving Credit Facility.

The Facility refinances the company’s existing EUR3.5bn Revolving Credit Facility signed in March 2005 which has never been drawn. The new credit line has a tenor of five years with two 1-year extension options and serves for general corporate purposes. BNP Paribas, Deutsche Bank and The Royal Bank of Scotland acted as Coordinators for the arrangement and syndication of the Facility.

The credit line was well received in the market and closed significantly oversubscribed, underlining Bayer’s strong standing in the bank market and its high-quality credit profile. In total, 29 institutions committed to the Facility.

Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. The company’s products and services are designed to benefit people and improve their quality of life. At the same time Bayer creates value through innovation, growth and high earning power. The Group is committed to the principles of sustainable development and to its role as a socially and ethically responsible corporate citizen. Economy, ecology and social responsibility are corporate policy objectives of equal rank. In fiscal 2010, Bayer employed more than 110,000 people and had sales of €35.1 billion. Capital expenditures amounted to €1.6 billion, R&D expenses to €3.1 billion. For more information, go to www.bayer.com.